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Abstract
Background: The Systematic Nomenclature of Medicine Clinical Terms (SNOMED CT) is being advocated as the
foundation for encoding clinical documentation. While the electronic medical record is likely to play a critical role
in pharmacovigilance - the detection of adverse events due to medications - classification and reporting of
Adverse Events is currently based on the Medical Dictionary of Regulatory Activities (MedDRA). Complete and high-
quality MedDRA-to-SNOMED CT mappings can therefore facilitate pharmacovigilance.
The existing mappings, as determined through the Unified Medical Language System (UMLS), are partial, and
record only one-to-one correspondences even though SNOMED CT can be used compositionally. Efforts to map
previously unmapped MedDRA concepts would be most productive if focused on concepts that occur frequently
in actual adverse event data.
We aimed to identify aspects of MedDRA that complicate mapping to SNOMED CT, determine pattern in
unmapped high-frequency MedDRA concepts, and to identify types of integration errors in the mapping of Med-
DRA to UMLS.
Methods: Using one years’ data from the US Federal Drug Administrations Adverse Event Reporting System, we
identified MedDRA preferred terms that collectively accounted for 95% of both Adverse Events and Therapeutic
Indications records. After eliminating those already mapping to SNOMED CT, we attempted to map the remaining
645 Adverse-Event and 141 Therapeutic-Indications preferred terms with software assistance.
Results: All but 46 Adverse-Event and 7 Therapeutic-Indications preferred terms could be composed using
SNOMED CT concepts: none of these required more than 3 SNOMED CT concepts to compose. We describe the
common composition patterns in the paper. About 30% of both Adverse-Event and Therapeutic-Indications
Preferred Terms corresponded to single SNOMED CT concepts: the correspondence was detectable by human
inspection but had been missed during the integration process, which had created duplicated concepts in UMLS.
Conclusions: Identification of composite mapping patterns, and the types of errors that occur in the MedDRA
content within UMLS, can focus larger-scale efforts on improving the quality of such mappings, which may assist in
the creation of an adverse-events ontology.
Background
The Systematic Nomenclature of Medicine Clinical
Terms (SNOMED CT) [1], originally developed by the
College of American Pathologists, and now managed by
the International Health Terminology Standards Devel-
opment Organization (IHTSDO) has been repeatedly
demonstrated to be the most comprehensive single-
source controlled vocabulary with respect to clinical
content coverage[2-7]. Consequently, there are efforts at
several levels toward making SNOMED CT the basis for
encoding of clinical documentation.
Adverse events following therapeutic interventions,
e.g., pharmaceutical preparations and medical devices,
are an important and often preventable, cause of mor-
bidity and mortality in patients. While some Adverse
Events are discovered through preclinical testing and
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majority are discovered during post-marketing safety
surveillance simply because of the much larger number
of patients who are exposed to the agent over longer
periods of time. With the push towards wider deploy-
ment of electronic medical records (EMRs), the EMR is
likely to become an increasingly important source of
Adverse Event discovery. Several efforts, notably by
Carol Friedman’s group at Columbia University, have
been directed at using natural-language processing
(NLP) techniques to determine the feasibility of detect-
ing Adverse Events in clinical text [8,9]. If such efforts
prove successful, it may become possible to enable
automated or semi-automated Adverse Event detection.
The US Federal Drug Administration’s Adverse Events
Reporting System (AERS)[10] supports post-marketing
surveillance. Reporting to the AERS is voluntary in the
US for primary health care providers and others, such
as patients, patient relatives, and lawyers. If, however,
such individuals have reported a problem to the agent’s
manufacturer, the latter is legally required to send the
report to the FDA. Within the US and internationally,
the controlled vocabulary that forms the basis of adverse
event reporting, both for post-marketing surveillance as
well as for drug agency-regulated clinical trials, is the
Medical Dictionary for Regulatory Activities (MedDRA)
[11], developed by the International Conference on Har-
monization (ICH). MedDRA includes concepts not only
for Adverse Events but also for the therapeutic indica-
tions for which the medication/device was employed.
The “Adverse Events” also include errors in prescribing,
dispensing and formulation of therapeutic agents, inter-
actions of drugs with other drugs or food, as well as
errors that were intercepted before they reached the
patient. Both SNOMED CT and MedDRA are compo-
nents of the Unified Medical Language System (UMLS)
[12], a compendium (“meta-thesaurus”)o fal a r g en u m -
ber of biomedical vocabularies that is distributed by the
National Library of Medicine (NLM).
If SNOMED CT becomes the basis for encoding clini-
cal documentation, NLP software that assists the encod-
ing of narrative text into SNOMED CT concepts may
eventually be bundled ubiquitously with EMR software.
Much NLP software, e.g., GATE [13] and MedLEE [14]
is implemented using a pipeline of individual modules,
each of which is specialized for a particular sub-task,
e.g., section and sentence segmentation, part-of-speech
tagging, and named-entity recognition. Rather than
creating special-purpose software to generate MedDRA
concepts directly from raw clinical text, vendors may
find it far simpler computationally to add a MedDRA-
generation module at the end of the existing pipeline, to
map SNOMED CT concepts into MedDRA equivalents.
Such a module will need to utilize a cross-mapping
between the SNOMED CT and MedDRA vocabularies.
It is therefore essential that these mappings be both
comprehensive and of high quality.
In this paper, we describe the issues that were
encountered in an exercise aimed at creating a map
between MedDRA and SNOMED CT, focusing on high-
frequency MedDRA terms for adverse reactions and
therapeutic indications in one year’sw o r t ho fA E R S
data, which was recorded between July 1, 2008 and
April 30, 2009. The motivation for this work is that, as
illustrated subsequently, the existing mappings between
MedDRA and SNOMED CT are limited and that there
are a variety of integration errors in the mapping of
MedDRA to UMLS, which is the starting point for our
efforts.
Our research objectives are stated below:
￿ To identify aspects of MedDRA that complicate
the process of mapping MedDRA concepts to
SNOMED CT.
￿ Through the attempted mapping of high-frequency
unmapped MedDRA concepts to SNOMED CT:
○ To categorize patterns that allow composition
of MedDRA concepts using SNOMED CT
concepts;
○ To identify possible lacunae in SNOMED CT
coverage of the adverse event domain;
○ To identify errors where a one-to-one mapping
of an unmapped MedDRA concept to a SNOMED
CT concept becomes apparent on human inspec-
tion, but has not been created in the UMLS.
￿ To identify patterns in the integration errors in the
mapping of MedDRA to UMLS.
An Overview of Terminological Issues related to MedDRA
Any attempt to cross-map between SNOMED CT and
MedDRA must commence with an understanding of the
strengths and limitations of each vocabulary. SNOMED
CT is designed along sound ontological principles. Due
to vigorous curation efforts, its content continues to
improve with each release. However, the vast size of
SNOMED CT - currently around 300 K active concepts
- limits the possibility of using all of its content as an
“interface terminology” [15], i.e., one intended to be
employed directly by end-users. The SNOMED CT doc-
umentation recommends the creation of subsets to
serve special purposes such as coding in clinical sub-
domains.
For the purpose of Adverse Event capture, MedDRA
has the relative advantage of brevity (65 K terms overall)
and it is conceivable that the equivalent SNOMED CT
concepts would form an “Adverse Event subset”.H o w -
ever, MedDRA’s design limitations, described in [16-18],
which are a consequence of its emphasis on classification,
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ness with respect to eventual query and analysis of AERS
data at various levels of granularity [19,20]. To be fair,
MedDRA’s creation antedates the current emphasis on
integrating ontological principles into controlled vocabu-
lary design, as in the case of SNOMED CT.
￿ Sophisticated controlled vocabulary designs such as
implemented in SNOMED CT and UMLS model
collections of concepts as graphs with an approxi-
mately hierarchical structure. There can be as many
levels of hierarchy as are considered appropriate: the
number of levels tends to be more for biomedical
sub-domains that have been studied for longer peri-
ods of time.
By contrast, MedDRA content is artificially con-
strained to a five-level hierarchy: System Organ Classes,
High Level Group Terms, High-level Terms, Preferred
Terms and Lower Level Terms. The FDA AERS records
indications and adverse reactions at the Preferred Term
level; there are about 18 K Preferred Terms in MedDRA
currently.
￿ Individual concepts in a vocabulary should be
allowed to descend from more than one parent if
necessary: for example, tuberculosis of the spine is
both a kind of tuberculosis and a disorder of the
spinal column. In MedDRA, this flexibility is artifi-
cially limited: Preferred Terms may descend from
more than one Higher-level Term, but a given
Higher-level Term or Higher-level Group Term may
descend from only one SOC. This leads to difficul-
ties in formulating queries.
￿ In MedDRA, there is no semantic consistency in
the relationship between a Lower-level term and a
Preferred Term. Some Lower-level terms are lexical
variants or synonyms of Preferred Terms - e.g., “cat-
aract, lenticular” is an Lower-level term for the Pre-
ferred Term “cataract” - but others are more
specific concepts that should really be coding con-
cepts in their own right - e.g, “diphtheritic myocar-
ditis” is an Lower-level term related to the Preferred
Term “diphtheria”. Determining the precise seman-
tics of the relationship requires human interpreta-
tion. In many cases (such as the cardiac
arrhythmias), the Lower-level terms for a given Pre-
f e r r e dT e r m ,i fl o o k e du pi nS N O M E DC T ,m a yb e
discovered to have hierarchical relationships among
themselves, but these cannot be modeled in Med-
DRA because a concept “lower” than an Lower-level
term is not permitted. The FDA AERS public data
provides Adverse Event details at the Preferred
Term level only; finer-level detail that may be
clinically relevant, in the case of more specific
concepts, is not accessible.
￿ MedDRA falls short with respect to several of
Cimino’s well-known controlled-vocabulary desider-
ata [21] in addition to the problems of hierarchy dis-
cussed above:
○ MedDRA is a non-compositional vocabulary:
that is, it is not possible to combine concepts to
form new concepts using specified operators. All
concepts used in MedDRA are pre-coordinated,
i.e., formed by synthesizing a phrase that com-
bines individual concepts, where the semantics of
the concept must be determined by human
inspection of the terms associated with the con-
cept. A large number of such pre-coordinated
concepts combine a laboratory test, e.g., “bone
alkaline phosphatase”,w i t ha“qualifier” attribute
that describes the result of the test qualitatively:
e.g., normal, abnormal, increased, decreased,
positive negative.
○ MedDRA uses semantically ambiguous qualify-
ing phrases such as “other/not otherwise speci-
fied” and “not elsewhere classified” in many
terms. Such concepts are hard to interpret
because they are valid only within a single voca-
bulary, and even here, are based on a criterion of
exclusion that is not time-invariant: more cate-
gories may subsequently be added, so that the
meaning of the concept drifts.
￿ Certain pre-coordinated concepts in MedDRA
(albeit concepts that do not appear to be used in
actual AERS data) are not clinically meaningful;.
An example category is “(substance) low”,w h e r e
the substance may be lead, cadmium, beryllium,
cyanide and several other toxic substances, whose
normal level in any tissue should be zero: the con-
cept of a “low” level is invalid. (There is a separate
concept “lead decreased” in MedDRA: this concept,
which refers implicitly to the presence of a pre-
vious measurement, can be meaningful when used
to describe the effect of chelation therapy in lead
poisoning.)
Existing Mappings between MedDRA and SNOMED CT
The content of the UMLS’sM R C O N S Ot a b l e ,w h i c h
contains mappings of concepts in individual source
vocabularies to concepts in the UMLS, can serve as the
starting point for mapping vocabularies to each other.
The overlap between all of the MedDRA concepts in
UMLS and SNOMED CT concepts is around 40%: how-
ever, 58% of preferred terms, the most useful part
o fM e d D R A ,m a pt oS N O M E DC T ,a sr e p o r t e db y
Bodenreider [22].
Nadkarni and Darer BMC Medical Informatics and Decision Making 2010, 10:66
http://www.biomedcentral.com/1472-6947/10/66
Page 3 of 10Our inspection of the MedDRA content that was
mapped to UMLS, however, revealed numerous pro-
blems that we describe in the Discussion section. In
addition, mapping between concepts in a pre-coordi-
n a t e dv o c a b u l a r yl i k eM e d D R Aa n dav o c a b u l a r yt h a t
allows composition (SNOMED CT) is not guaranteed to
be one-to-one. For example, most laboratory-related
MedDRA concepts that conflate the test measurement
with the qualitative result do not occur in SNOMED
CT, but need to be composed by combining the concept
of the measurement with a SNOMED CT “qualifier”
concept like “increased” or “elevated”. We later consider,
in the Discussion, some of the analytical issues that this
approach raises.
Methods
The 2009AA release of the UMLS and Jan’09 release of
SNOMED CT, obtained from the UMLS Knowledge
Server, were used for this work.
Source of Adverse-Event Frequency Data
Version 11.1 of MedDRA contains 18,209 Preferred
Terms. In order to focus our mapping efforts, we
assumed that every Preferred Term would be unlikely to
occur in actual FDA AERS data, and that a relatively
modest proportion of Preferred Terms would account
for the majority of actual AERS records. Data for the
study was therefore obtained from the FDA AERS
download site [23] in order to identify the Preferred
Terms that occurred with high frequency. We decided
to select those Preferred Terms that collectively
accounted for more than 95% of the AERS therapeutic
indications and adverse event records: the 95% threshold
has been used in other initiatives, such as the NLM’s
SNOMED CT CORE Subset [24].
Data Set Characteristics
The characteristics of the data set are given in Table 1
below.
Mapping of Unmapped Preferred Terms
The first author developed a SNOMED CT browser/
concept-searcher using Microsoft SQL Server 2008 to
host the Jan ‘09 SNOMED CT content, with a stored-
procedure library written using Visual Basic .NET 2008,
and a browsing front-end created using Microsoft
Access 2003. The SNOMED CT content was augmented
with single-word synonym content from the Unified
Medical Language System (i.e., all terms in UMLS for a
given SNOMED concept where one of the terms com-
prises a single lexical token). This software will be made
available freely on request to the first author; however,
its use is not critical to this work, and alternative con-
cept-searching software, such as the popular CLUE
browser http://www.clininfo.co.uk, could have been
used.
The user specifies search terms either by pasting the
MedDRA term into a text box, or entering keywords
manually. (The software can also run in batch mode:
this mode was used to fetch matching candidates into a
table for subsequent manual inspection and selection.)
Concepts matching one or more words in the search
phrase are returned using the well-known “Term Fre-
quency * Inverse Document Frequency” (TF*IDF)[25]
approach for relevance-ranking of search results. The
concept-searching process eliminates stop-words from a
search phrase (very common words in a language that
have minimal search value) using the PubMed stop-
word set [26]. The remaining words in the phrase are
lemmatized [27], i.e., conversion to root forms (lemmas)
by eliminating variations in tense and person using the
program morph, part of the well-known Wordnet the-
saurus/software [28]. Lemmatization can sometimes
yield more than one lemma from a given word e.g., the
lemma of “leaves” can be “leaf” or “leave”, depending on
whether “leaves” is a plural noun or a verb. Lemmatiza-
tion results in query expansion because the lemmatized
words are searched against a lemmatized word index.
Further query expansion is performed electronically
Table 1 Characteristics of the FDA AERS Data Set used to identify high-frequency concepts
Therapeutic Indications Data Adverse Events Data
A. Number of records in data set (each record contains 1 Preferred Term) 850 K 1.19 M
B. Unique Preferred Terms in data set 5,540 10,304
C. Number of unique Preferred Terms already mapped
to SNOMED CT in UMLS
3864 (69.7%) 6,409 (62.2%)
D. Number of unique Preferred Terms accounting for
>95% of records ("high-frequency” Preferred Terms)
834 (15.1%), accounting
for 60+ records each
2,871 (27.9%), accounting
for 32+ records each
E. Number of high frequency Preferred Terms already
mapped to SNOMED CT in UMLS
693 (83.1%) 2,226 (77.5%)
F. Number needing manual mapping (D-E) 141 645
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word and other equivalences (e.g., hepatic/liver, gastric/
stomach, neoplasm/tumor).
The IDF*TF approach is most appropriate for circum-
stances where a single concept in SNOMED CT is likely
to contain all or most of the words in the MedDRA
term. However, a preliminary search of unmapped Med-
DRA terms had revealed a large number of terms where
post-coordination would be necessary, e.g., when a lab
test is combined with a single-word qualifier. Here,
using the IDF*TF approach to retrieving every
SNOMED CT concept that contains at least one word
in the search term would return a prohibitive number of
concepts. Therefore, the software additionally tries to
simultaneously locate SNOMED CT concepts with
synonymous terms corresponding to single words in the
s e a r c hp h r a s e .T h i si su s e f u lf o rt e r m ss u c ha s“CYTO-
MEGALOVIRUS CHORIORETINITIS” and “HAEMA-
TOCRIT ABNORMAL”.
Results
The results of the mapping process are shown in Table 2
below.
The details of the mappings are available in the online
data supplement (Additional File 1) that accompanies
this paper. We summarize the highlights of the mapping
below: when we use a concept ID of the form Cnnnnn,
we refer to the UMLS CUI.
Compositional Patterns
As expected, many MedDRA Preferred Terms had to be
composed using more than one SNOMED CT concept:
other than the “missing concepts” below, none required
more than three SNOMED CT concepts to compose.
The following types of composite forms were
encountered:
<observation of laboratory test>
<qualitative result>;
<organism> < “infection ”/“bacteremia”/“sepsis”>;
<malignancy> < “stage”/“recurrent”/“metastatic”>;
<pharmacological-action> < “therapy”/“supportive
care”>;
<disease> “prophylaxis”;
<body part> “pain”/“inflammation”/“injury”;
<organ system> “toxicity”.
(Strings are denoted in quotes, while unquoted
phrases refer to a concept category. Slashes refer to
alternatives within a pattern, while carets are used to
denote a group within a pattern.)
Concepts Missing in SNOMED CT
Some concepts were missing in SNOMED CT. Among
Adverse Events, errors in prescription or administration
of a drug are under-represented in SNOMED CT, and
concepts such as therapy cessation, device leaks/break-
age, off-label use, product contamination, tampering,
counterfeiting and quality issues may be expected to be
missing. Omissions of clinical coverage include multiple
drug resistance (to antibiotics), propofol infusion syn-
drome, compulsive shopping behavior, and intrauterine
device migration, paternal drugs affecting fetus. Among
Indications, concepts not expected to be in SNOMED
CT are “Drug use for unknown indications” (the highest-
frequency indication); “evidence-based treatment” and
“unevaluable event”. Clinical coverage omissions
are breakthrough pain (seen in patients receiving narco-
tics for terminal illness) and “bone marrow conditioning
regimen”. Some of the indications terms are also
Adverse-Event Terms (paternal drugs affecting fetus, off-
label use).
The common concept of post-procedural complica-
tions is not represented in SNOMED CT and needs to
be composed. A family of MedDRA Preferred Terms
that required three SNOMED CT concepts to map was
the qualitative results of therapeutic drug monitoring.
These had to be expressed using SNOMED CT concept
365750008 ("Finding of therapeutic drug level”), the
drug family (e.g., anticonvulsant), and the qualitative
result.
Unmapped MedDRA concepts matching single SNOMED
CT concepts
What was surprising was that about 30% of the
“unmapped” Preferred Terms for both indications and
Adverse Events were found to map to single SNOMED
CT concepts, indicating insufficient checking of these
Table 2 Results of the mapping process
Indications Preferred
Terms
Adverse Event Preferred
Terms
Total number of Preferred Terms requiring manual mapping (Table 1, row F) 141 645
Preferred Terms not in SNOMED CT and not composable from existing SNOMED CT
concepts
74 6
Preferred Terms mapping to a single SNOMED CT concept (missed synonyms) 45 195
Preferred Terms composable from two SNOMED CT concepts 87 373
Preferred Terms composable from three SNOMED CT concepts 2 31
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process prior to characterizing them to distinct concepts
in UMLS. This missed synonymy results in redundancy
in UMLS content. Many of these were synonyms (e.g.,
dysphemia C1096340 = stuttering C0038506); word var-
iants (feeling guilty C0877289 = feeling guilt (finding)
C0018379); abbreviations (hip dysplasia C1328407 =
congenital acetabular dysplasia (disorder) C0431952 -
hip dysplasia, by definition, is never “acquired”).
The problem of missed synonymy in the UMLS was
identified by Hole and Srinvasan in a 2000 paper [29]
and is admittedly a difficult one to solve. As we empha-
size shortly, the concept redundancy problem is much
more prominent for MedDRA’s lower-level terms, many
of which are synonyms for existing concepts rather than
concepts in their own right.
Discussion
Issues with the MedDRA content in UMLS
The process of integrating a source vocabulary into
UMLS involves identifying the source-vocabulary con-
cepts that correspond to existing UMLS concepts. Con-
cepts where such correspondences are not found are
designated as new concepts that will be assigned UMLS
Concept IDs. However, the NLM performs limited cura-
tion, relying partly on automated methods, and to
some extent on the diligence and knowledge of source-
vocabulary curators of the individual source vocabularies
for this process. In any case, errors in the original Med-
DRA content can propagate to UMLS. Several types of
errors can be detected in the source-vocabulary-
to-UMLS mapping process, but their detection typically
requires content expertise and manual inspection; some
of these, indicated with a double asterisk, are due to
undetected problems in the original MedDRA content.
￿ Missed Synonymy: Many concepts in MedDRA
become new, duplicated concepts in UMLS: We
have provided some examples earlier. Additional
causes of missed synonymy include British vs. Amer-
ican spellings: For example, both “Aluminium”
(IUPAC/British) and “Aluminum” (US) occur in
phrases involving the metal. For example, we have
the MedDRA derived “Blood aluminium (& level (&
serum))” C1578975” and SNOMED CT derived
“Serum aluminum level” C1318288.
￿ Improper Designation of Synonymy: Many pairs of
distinct concepts are treated incorrectly as though
they were synonyms.
○ * *I nt h ec a s eo fq u a l i t a t i v el a b o r a t o r yr e s u l t s ,
MedDRA does not appear to distinguish
“increased” from “high”,o r“decreased” from “low”:
it treats these pairs (loosely) as interchangeable
synonyms. Thus, there are the concepts “Digoxin
level high” C0581164, and “Digoxin level
decreased” C0920128), but there is no concept
“Digoxin level increased”. Strictly speaking,
“increased” and “decreased” imply comparison to a
previous value, which has relevance to the thera-
peutic drug monitoring that is employed for
Digoxin, while “high” and “low” refer to values
above or below normal/therapeutic ranges.
SNOMED CT differentiates between “high” (syno-
nym “elevated”)a n d“increased” by placing them in
different sub-hierarchies.
○ ** MedDRA tends to use “carcinoma” as a
synonym for malignancy/cancer, whereas the
term strictly refers to a malignancy of ectodermal
or endodermal origin, as opposed to a “sarcoma”
that derives from mesoderm. Thus, MedDRA has
the concept of “gastrointestinal carcinoma”,b u t
does not record the (admittedly rarer) concept of
gastrointestinal sarcomas, or the general concept
“gastrointestinal cancer” as a distinct concept.
￿ ** Certain medical phrases that commonly occur in
concepts are used loosely, so that they become new
concepts in UMLS that, on closer inspection by
someone with a background in laboratory medicine,
would turn out to be invalid. For example, Med-
DRA’su s eo f“Blood” encompasses serum, plasma
and blood as the sample source, while SNOMED
CT’s use is precise. So the MedDRA-derived
“blood prolactin” C0853129 does not exist as a
SNOMED CT concept (whole blood is not used for
prolactin assays, so that the concept of a “blood pro-
lactin assay” is invalid), though “plasma prolactin”
C0857712 does.
￿ ** The unclear relationship between MedDRA pre-
ferred terms and lower-level terms results in spur-
ious concepts in UMLS and inaccurate relationships.
For example, In the UMLS-MedDRA content, “anti-
mony normal” C0861045 is treated as a distinct con-
cept from “blood antimony normal” C0855863.
Interpreted in isolation in UMLS, the former con-
cept is inherently ambiguous (it does not specify the
tissue that was sampled). Inspection of the details of
the two concepts, however, reveals that in MedDRA,
“antimony normal” is a lower-level term correspond-
ing to the preferred term “blood antimony normal”.
This should indicate that it is a synonym: it cannot
be a more specific type of antimony measurement,
since “any” tissue is more general than “blood”. Note
that, this concept is also meaningless clinically:
organic antimonials are used only in the treatment
of schistosomiasis and leishmaniasis, and the “nor-
mal” level is zero.
￿ Sometimes, MedDRA concepts are matched to the
wrong UMLS concept. An example is “Chemistry”,
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science (like physics and biology). The term “chemis-
try”, however, is known to be a homonym (a word
with multiple, separate meanings) in English, and an
inspection of the MedDRA-derived relationships of
this concept in UMLS reveals that it is an Lower-
level term corresponding to the Preferred Term
“Laboratory Procedure”, indicating that it is really a
synonym (a non-preferred, abbreviated form) for
“Serum Chemistry Test”. Many scientific phrases are
semantically ambiguous in isolation, and the
accepted way to address these is by the use of
descriptive concept definitions (a mammoth curator-
ial task where all existing terminologies fall short)
and/or the labeling of certain terms as ambiguous
(a process followed by SNOMED CT and UMLS).
MedDRA, however, lacks concept definitions
entirely, and there is no recognition or labeling of
term ambiguity within its content: the meaning of a
term must often be inferred from its position in a
hierarchy. Consequently, errors of this kind are less
likely to be detected.
A sac o n s e q u e n c eo ft h ea b o v ei s s u e s ,t h ee x i s t i n g
mapping in UMLS between SNOMED CT and Med-
DRA is problematic and needs to be carefully checked.
In particular, the excessive incorporation of synonymous
MedDRA Lower-level terms as new concepts in UMLS
vitiates UMLS’s intended role as a “Rosetta stone”.
Dealing with MedDRA Concepts based on Laboratory
Parameters
As discussed previously, to map a large number of Med-
DRA concepts based on laboratory parameters to
SNOMED CT equivalents, one needs to combine the con-
cept of the laboratory test measurement with a “qualifier”
concept describing the qualitative result of the result, e.g.,
normal, high or low. This approach may satisfy the objec-
tive of mapping, but it does not address the problem of
analyzability of the resulting SNOMED CT-encoded data.
￿ In the EMR, laboratory data is typically recorded in
structured form rather than reproduced in the
unstructured clinical narrative. The EMR’s laboratory-
data subsystem has standard methods of determining
whether a given result is in the normal range, based on
reference/laboratory standards and the patient’sa g e
and sex: the clinician can additionally bring informa-
tion on other physiological states such as pregnancy to
bear on the result. The task of generating appropriate
MedDRA codes from structured laboratory data is
algorithmically far simpler than trying to do the same
with narrative text: such text may contain only the
numerical values of the lab parameters, whose names
are often reported in abbreviated form without
mention of reference range or even units.
￿ Laboratory measurements are currently not mod-
eled in detail in SNOMED CT: they are mostly “pri-
mitive” concepts rather than fully defined. This
makes such mappings less useful than mappings to,
say, clinical diagnoses.
￿ It is well known that “Qualifier” concepts, such as
used to describe qualitative results, are currently one
of the least developed aspects of SNOMED CT: Rec-
tor and Brandt [30] show that for many circum-
stances where they are used, more formal
approaches would be preferable. They do not allow
even limited electronic reasoning of the kind that is
useful for Adverse Events - for example, that for cer-
tain tests, “abnormal” and “high” are synonymous,
while for others (such as serum electrolytes and hor-
mone levels), both “high” and “low” are abnormal
results. This is partly because of the lack of
any detailed computable semantics associated with
individual qualifiers, which makes it easy to misuse
“elevated” when “high” is intended, for example.
The use of ordinal domains [31] -sets of permissible
values for a laboratory-result concept that can describe a
result qualitatively, based on a quantitative definition of
normal - allows straightforward electronic reasoning. Such
reasoning is implemented routinely by laboratory report-
ing systems that place an “H(igh)” or “L(ow)” against a
numeric value, and would be extremely difficult if a purely
qualifier-based approach to reasoning were adopted.
The lack of ordinal-value support is a common pro-
blem in ontologies that is not limited to SNOMED CT.
There is no intrinsic reason, however, why such support
- a standard aspect of database/analytics knowledge
representation for over three decades - cannot be sys-
tematically integrated with ontologies in knowledge
domains where such support is called for. The latest
incarnation of the Web Ontology Language, OWL 2,
seems to be moving in this direction, with improved
support for mathematical operations as well as more
expressive constraints[32]. The SNOMED CT concept
model for observables is under active revision, but its
current draft version (0.03) does not provide support for
ordinal-value representation.
Toward a Comprehensive Ontology of Adverse Events
In this section, we discuss the implications of the work
described.
Even if NLP techniques are able to match concepts in
clinical text to Adverse Events with high accuracy, they do
not address the problem of eventually aggregating the
results in meaningful ways for analysis. In clinical narra-
tive, certain concepts may be specified explicitly by the
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their presence must be inferred from their known relation-
ship to other concepts that occur in the narrative.
For example, in the paper of Wang et al (the Columbia
group) [8], phrases encountered in various patients
undergoing treatment with bupropion (used as an anti-
depressant as well as for smoking cessation) included
“extrapyramidal sign”, “stiffness”,a n d“motor retarda-
tion”. The authors do not recognize that the latter two
symptoms are part of the extrapyramidal syndrome when
occurring together (though each in isolation can have
other causes), and an analysis that treated these terms as
isolated entities would under-count the extrapyramidal
findings. (MedDRA contains information about sets of
individual findings that, when co-occurring, suggest spe-
cific syndromes. This information, the Standardized
MedDRA Queries (SMQs), was created to facilitate data
mining, and there is already an SMQ for Extrapyramidal
Syndrome. The authors did not use SMQ data, which is
available in the UMLS Rich-Release format, to attempt to
improve the accuracy of their results.)
The availability of high-quality adverse events infor-
mation content, which reliably records relationships
between Adverse-Event concepts more comprehensively
than MedDRA does currently, can improve the quality
and productivity of Adverse-Event data analysis and
data-mining, by minimizing the effort involved in ad-
hoc creation of aggregate groupings that need to be
replicated by every research group working with such
data. The availability of Gene Ontology [33] has had
such benefits in the gene-expression microarray field, by
facilitating the summarization of signals from thousands
of genes into fewer, more readily interpretable categories
using gene-family and pathway labels.
An Adverse-Events ontology does not currently exist.
The work reported in [34] has, however, explored the
manual construction of such an ontology for the limited
domain of hepatitis. MedDRA’s design is not sufficiently
robust to serve as the foundations of such an ontology,
though its Preferred Terms may serve as the nodes of
interest, and the SMQ content is also essential. The sub-
set of SNOMED CT that maps to MedDRA (along with
intermediate SNOMED CT concepts in the network
that are discovered in the cross-mapping process) is
more suitable for the ontology scaffolding. The work
described in [35,36] has explored and confirmed this
possibility for limited sub-domains such as “hemor-
rhage": this work has identified the need for new inter-
concept relationship types (attributes) that are specific
to the adverse-event domain. The work of Bodenreider
[8] has also explored such issues, employing cross-
mapping from MedDRA to SNOMED by automated
approaches to actually quantify the intermediate-level
SNOMED CT concepts.
The major use-case for a standardized, validated and
freely available adverse-event ontology is to serve as the
basis for eventually encoding existing knowledge about
drug or device-related adverse events. Currently, most
commercially distributed drug databases record adverse
effects as narrative text reproduced from the FDA pack-
age insert: where information is encoded, International
Classification of Diseases (ICD) diagnosis codes are
used, so that the numerous (non-billable) subjective or
objective findings that are not full-fledged diagnoses are
not represented. The variability of narrative text makes
it difficult to answer the question: given the presence of
a particular clinical finding, which of the medications
that the patient is taking could be responsible, and what
is the likelihood (expressed on an ordinal scale) of indi-
vidual medications contributing? It is clear that many of
the issues involved in knowledge representation (includ-
ing representation of SMQs) go beyond the strictly
“ontological” - indeed, existing ontology-modeling tools
and paradigms may prove a poor match for several
aspects of the modeling of the adverse-event component
alone. The effort required will be vast, requiring the
resources of national/international organizations, but we
hope that the initial exploration described here will pro-
vide signposts to potential minefields.
Limitations of the present work
The limitations of this work include the following:
￿ The mappings that we have performed may con-
tain errors, or be disputed by others. This paper is
concerned primarily with the discovery of composi-
tion patterns as well as the MedDRA quality issues
that were discovered during the attempted mapping.
We have, however, provided a downloadable online
appendix containing the mappings (as an Excel
spreadsheet) as a companion to this paper.
￿ The numerous existing mappings of MedDRA to
SNOMED CT in UMLS were not checked exhaus-
tively: it is likely that there may be errors in addition
to the ones that were caught in our exploration.
￿ Mappings between any two vocabularies with dif-
ferent underlying designs and incomplete overlap are
necessarily directional. Our work only considers
mapping from the non-compositional, smaller, Med-
DRA to the compositional, larger SNOMED CT.
The reverse scenario - mapping SNOMED CT-
encoded content from the clinical narrative to Med-
DRA concepts - has not been addressed. This can be
challenging in cases where SNOMED CT concepts
are recognized in clinical text by automated meth-
ods: such methods by their nature tend to discover
simple, “primitive” concepts rather than highly com-
posite ones (especially those that involve negation).
Nadkarni and Darer BMC Medical Informatics and Decision Making 2010, 10:66
http://www.biomedcentral.com/1472-6947/10/66
Page 8 of 10Also, certain MedDRA concepts such as “wrong
technique in drug usage process” must be inferred
from the narrative, because they are rarely if ever
explicitly stated as such.
Conclusions
The design of MedDRA, in particular the failure to dis-
tinguish between lower-level terms that are synonyms of
preferred terms as opposed to those that are distinct but
finer-grained concepts, poses problems for the MedDRA
content in UMLS. In addition, the existing integration
approach has resulted in a significant proportion of
duplicate concepts being added to UMLS. This content
needs a detailed audit, because most researchers use
UMLS as the source of MedDRA content rather than
paying a significant subscription fee to the MedDRA
Maintenance and Support Organization.
O n ec h a l l e n g ei no t h e rg r o u p s ’ building on the work
described here is the currently very limited deployment
of SNOMED CT in EMRs: a combination of factors
such as licensing issues, vocabulary size, vendor unfami-
liarity with ontological principles, and vendor inertia are
responsible: in the USA, the last can be partly attributed
to the fact that, while abstraction of clinical text for
ICD-9 diagnoses is mandated for billing and reimburse-
ment purposes, it is harder to justify the software devel-
opment to assist SNOMED CT-encoding of clinical
encounters (which is also much more extensive than
diagnoses or procedure encoding) on a purely economic
basis. Also, while SNOMED CT has the advantage of
allowing post-coordination, error-free post-coordination
either by local curators or clinicians requires intuitive
and responsive software that is driven by a machine-
readable concept model (an area of active development
b yt h eI H T S D O ) .W ea r eo p t i m i s t i c ,h o w e v e r ,t h a tt h e
widespread adoption of SNOMED CT across EMRs will
happen within a reasonable timeline. Once this happens,
application of the SNOMED CT infrastructure to areas
such as adverse-event capture will become a reality.
Availability of Software
T h es o f t w a r eu s e db yt h ea u t h o rt op e r f o r mt h em a p -
ping will be made freely available on request.
Additional material
Additional file 1: Mappings of SNOMED Terms to MedDRA
equivalents. There are three worksheets in this workbook. The READ ME
worksheet documents the contents of the other two worksheets. The
sheet MedDRA_AEs records mapping of adverse event preferred terms
to SNOMED concepts. The sheet MedDRA_indications records mappings
of therapeutic indications to SNOMED concepts.
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